Antibody Therapy in the Management of Shiga Toxin-Induced Hemolytic Uremic Syndrome

Clinical Microbiology Reviews - United States
doi 10.1128/cmr.17.4.926-941.2004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

New Insights Into Shiga Toxin-Mediated Endothelial Dysfunction in Hemolytic Uremic Syndrome

Virulence
ParasitologyInfectious DiseasesImmunologyMicrobiology
2013English

Shiga Toxin-Producing Escherichia Coli Associated Hemolytic Uremic Syndrome (STEC-HUS)

Japanese Journal of Thrombosis and Hemostasis
2020English

Shiga Toxin-Associated Hemolytic Uremic Syndrome: Interleukin-1 Beta Enhancement of Shiga Toxin Cytotoxicity Toward Human Vascular Endothelial Cells in Vitro.

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
1993English

Shiga Toxin-Associated Hemolytic Uremic Syndrome: Combined Cytotoxic Effects of Shiga Toxin and Lipopolysaccharide (Endotoxin) on Human Vascular Endothelial Cells in Vitro.

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
1992English

Prevention of Hemolytic Uremic Syndrome With Daily Bowel Lavage in Patients With Shiga Toxin–Producing EnterohemorrhagicEscherichia coliO104:H4 Infection

JAMA Internal Medicine
Internal Medicine
2014English

D+ Hemolytic Uremic Syndrome

Paediatrica Indonesiana
2016English

Atypical Hemolytic-Uremic Syndrome

2020English

Hemolytic Uremic Syndrome Surveillance to Monitor Trends in Infection With Escherichia Coli O157:H7 and Other Shiga Toxin-Producing E. Coli

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
1997English

Electrolyte Excretion in the Hemolytic Uremic Syndrome.

Nihon Shoni Jinzobyo Gakkai Zasshi
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy